KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-Current Assets (2016 - 2026)

Emergent BioSolutions has reported Non-Current Assets over the past 17 years, most recently at $682.8 million for Q1 2026.

  • For Q1 2026, Non-Current Assets fell 5.07% year-over-year to $682.8 million; the TTM value through Mar 2026 reached $2.7 billion, down 14.91%, while the annual FY2025 figure was $656.1 million, 17.05% down from the prior year.
  • Non-Current Assets for Q1 2026 was $682.8 million at Emergent BioSolutions, up from $656.1 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.0 billion in Q4 2022 and troughed at $656.1 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: rose 15.88% in 2022 and later crashed 41.53% in 2023.
  • Year by year, Non-Current Assets stood at $2.0 billion in 2022, then crashed by 41.53% to $1.1 billion in 2023, then plummeted by 30.84% to $791.0 million in 2024, then dropped by 17.05% to $656.1 million in 2025, then rose by 4.07% to $682.8 million in 2026.
  • Business Quant data shows Non-Current Assets for EBS at $682.8 million in Q1 2026, $656.1 million in Q4 2025, and $674.1 million in Q3 2025.